相关实验视频
Updated: Feb 12, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
在炎症性肠道疾病的治疗目标:从实用性临床试验中查的教训
Jason K Hou1,2, Jasmine Nguyen3, Jorge Rodriguez-Gaytan2
1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
Crohn's & colitis 360
|February 11, 2026
概括
在炎症性肠病 (IBD) 中,许多患者获得了症状缓解,但没有内镜缓解. 大多数患者更愿意继续他们目前的先进疗法而不是切换,即使在内镜治疗无法实现时也是如此.
科学领域:
- 胃肠病学 胃肠病学
- 临床试验 临床试验
- 炎症性肠道疾病研究研究
背景情况:
- 在炎症性肠病 (IBD) 中,治疗到目标 (TTT) 的目标是临床和内镜缓解.
- 在接受先进疗法的IBD患者中,症状缓解并不总是等同于内镜治疗.
- 关于异调和患者对先进治疗管理的偏好的现实数据有限.
研究的目的:
- 确定IBD中症状和内镜异常的现实世界流行率.
- 评估患者和提供者在IBD中继续或切换先进治疗方面的偏好.
- 评估患者接受先进治疗调整的情况,当内镜缓解不能实现时.
主要方法:
- QUOTIENT试验进行了选练习,以估计不一致性流行率.
- 用详细的查日志来评估符合条件的IBD患者.
- 记录了患者和提供者的参与意愿和偏好.
主要成果:
- 在761名查的IBD患者中,12%接受先进治疗和症状缓解的患者患有中度至严重的内镜炎症.
- 临床试验参与率下降的主要原因是患者更愿意继续接受当前的先进疗法 (39%).
- 只有11%的人因更喜欢转换先进治疗而拒绝参与.
结论:
- 在IBD患者中,真实世界内镜缓解率高于临床试验表明的水平.
- 显著的患者偏好存在于维持当前的先进疗法,与提供者TTT目标形成鲜明对比.
- 患者的偏好在IBD的先进治疗管理决策中起着至关重要的作用.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.1K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management
639
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
639
Inflammatory Bowel Disease IV: Pharmacological Management
718
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
718
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K

